Developing diagnostic criteria in Waldenstrom's macroglobulinemia

Seminars in Oncology

Volumn 30, Issue 2, 2003, Pages 196-200

  Owen, Roger G ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN M;

B LYMPHOCYTE; BONE MARROW; DIAGNOSTIC PROCEDURE; GENOTYPE; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MONOCLONAL IMMUNOGLOBULINEMIA; MORPHOLOGY; PLASMA CELL; PRIORITY JOURNAL; REVIEW; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0037396124     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2003.50069     Document Type: Review

References (40)

1. Waldenstrom J: Incipient myelomatosis or essential hyperglobulinemia with fibrinogenopenia - A new syndrome? Acta Med Scand 117:216-247, 1944
2. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, et al: Waldenstrom's macroglobulinemia: Clinical features, complications, and management. J Clin Oncol 18:214-226, 2000
3. Owen RG, Johnson SA, Morgan GJ: Waldenström's macroglobulinaemia: Laboratory diagnosis and treatment. Hematol Oncol 18:41-49, 2000
4. Bennett JM, Catovsky D, Daniel M-T, et al: Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 42:567-584, 1989
5. Kyle RA, Garton JP: The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62:719-731, 1987
6. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
7. Jaffe ES, Harris NL, Stein H, et al: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. Lynon, France, IARC, 2001
8. The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's lymphoma. Blood 89:3909-3818, 1997
9. Owen RG, Parapia LA, Richards SJ, et al: Paraprotein status in lymphoplasmacytoid lymphoma/immunocytoma: Do all cases correspond to Waldenstrom's macroglobulinaemia? Br J Haematol 105:89, 1999 (suppt 1, abstr)
10. Papamichael D, Norton AJ, Foran JM, et al: Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996. J Clin Oncol 17:2847-2853, 1999
11. H gene analysis of clonally related IgM and IgG from human lymphoplasmacytoid B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG. Blood 91:236-243, 1998
12. Owen RG, Parapia LA, Higginson J, et al: Clinicopathological correlates of IgM paraproteinemias. Clin Lymph 1:39-43, 2000
13. Facon T, Brouillard M, Duhamel A, et al: Prognostic factors in Waldenstrom's macroglobulinemia: A report of 167 cases. J Clin Oncol 11:1553-1558, 1993
14. Gobbi PG, Bettini R, Montecucco C, et al: Study of prognosis in Waldenstrom's macroglobulinemia: A proposal for a simple binary classification with clinical and investigational utility. Blood 83:2939-2945, 1994
15. Morel P, Monconduit M, Jacomy D, et al: Prognostic factors in Waldenström macroglobulinemia: A report on 232 patients with the description of a new scoring system and its validation on 253 other patients. Blood 96:852-858, 2000
16. Owen RG, Barrans SL, Richards SJ, et al: Walddenström macroglobulinemia: Development of diagnostic criteria and identificacion of prognostic factors. Am J Clin Pathol 116:420-428, 2001
17. Garcia-Sanz R, Montoto S, Torrequebrada A, et al: Waldenström macroglobulinaemia: Presenting features and outcome in a series with 217 cases. Br J Haematol 115:575-582, 2001
18. Kyrtsonis MC, Vassilakopoulos TP, Angelopoulou MK, et al: Waldenström's macroglobulinemia: Clinical course and prognostic features in 60 patients. Ann Hematol 80:722-727, 2001
19. Bartl R, Frisch B, Mahl G, et al: Bone marrow histology in Waldenstrom's macroglobulinaemia. Scand J Haematol 3:359-375, 1983
20. Owen RG, Lubenko A, Savage J, et al: Autoimmune thrombocytopenia in Waldenström's macroglobulinemia. Am J Hematol 66:116-119, 2001
21. Stone MJ: Studies on monoclonal antibodies, I: The specificity and binding properties of a Waldenström macroglobulin with anti-G activity. J Lab Clin Med 81:393-409, 1973
22. Krause MD: Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. One disease or three? Am J Clin Pathol 116:799-801, 2001
23. Andriko JW, Aguilera NS, Chu WS, et al: Waldenström's macroglobulinemia. A clinicopathologic study of 22 cases. Cancer 80:1926-1935, 1997
24. Feiner HD, Rizk CC, Finfer MD, et al: IgM monoclonal gammopathy/Waldenström's macroglobulinemia: A morphological and immunophenotypic study of the bone marrow. Mod Pathol 3:348-356, 1990
25. Matutes E, Owusu-Ankomah K, Morilla R, et al: The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640-1645, 1994
26. San Miguel JF, Vidriales MB, Mateo G, et al: Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Semin Oncol 30:187-195, 2003
27. Palka G, Spadano A, Geraci L, et al: Chromosome changes in 19 patients with Waldenstrom's macroglobulinemia. Cancer Genet Cytogenet 29:261-269, 1987
28. Louviaux I, Michaux L, Hagemeijer A, et al: Cytogenetic abnormalities in Waldenstom's disease (WD): A single center study on 45 cases. Blood 92:3776, 1998 (suppl 1, abstr)
29. Carbone P, Caradonna F, Granata G, et al: Chromosomal abnormalities in Waldenström's macroglobulinemia. Cancer Genet Cytogenet 61:147-151, 1992
30. Mansoor A, Medeiros J, Weber DM, et al: Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol 116:543-549, 2001
31. Schop RFJ, Kuehl WM, Van Wier SA, et al: Waldenström's macroglobulinemia neoplastic cells lack IgH translocations but have frequent 6q deletions. Blood 100:2996-3001, 2002
32. Offit K, Parsa NZ, Filippa D, et al: t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 80:2594-2599, 1992
33. Iida S, Rao PH, Nallasivam P, et al: The t(9;14)(p13; q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88:4110-4117, 1996
34. Zarrabi MH, Stark RS, Kane P, et al: IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia. Am J Clin Pathol 75:1-10, 1981
35. Haghighi B, Yanagihara R, Cornbleet PJ: IgM myeloma: Case report with immunophenotypic profile. Am J Clin Pathol 59:302-308, 1998
36. Konda H, Yokoyama K: IgM myeloma: Different features from multiple myeloma and macroglobulinaemia. Eur J Haematol 63:366-368, 1999
37. Avet-Loiseau H, Garand R, Lodé L, et al: Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood 101:1570-1571, 2003
38. Takahashi K, Yamamura F, Motoyama H: IgM myeloma - Its distinction from Waldenström's macroglobulinemia. Acta Pathol Jpn 36:1553-1563, 1986
39. Dierlamm T, Laack E, Dierlamm J, et al: IgM myeloma: A report of four cases. Ann Hematol 81:136-139, 2002
40. Sahota S, Forconi F, Ottensmeier CH, et al: Typical Waldenström macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood 100:1505-1507, 2002